Our FDA: Drug & Device Team examines the FDA’s new draft guidance that allows biosimilar developers to rely more on…
Read More →
Artificial intelligence is no longer an emerging concept in e-discovery—it’s a working reality. Every day, legal and compliance teams are…
Read More →
Recent bipartisan privacy and online safety initiatives reflect growing concern over youth mental health, online exploitation, and manipulative digital design.…
Read More →
In Antitrust analysis in the United States, the Small but Significant Non-Transitory Increase in Price (“SSNIP”) test is often a…
Read More →
New rules under the General Product Safety Regulation (EU) 2023/988 (GPSR) have applied since 13 December 2024 across the European…
Read More →
Personal injury lawyers throughout the U.S. advertise with billboards and commercials showing car accidents. But Florida, like a handful of…
Read More →
In August 2025, a pair of California parents filed suit in California state court against OpenAI (Raine v. OpenAI, Inc.)…
Read More →
The recent unanimous California Supreme Court opinion in Whitehead v. City of Oakland addressed the permissible scope of pre-event liability…
Read More →
In a landscape where the average cost of a data breach reached an all-time high of $4.88 million in 2024…
Read More →
The European Securities and Markets Authority (ESMA) has announced that cyber risk and digital resilience will remain central to its…
Read More →